ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 187 filers reported holding ACORDA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.38 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $2,290,000 | – | 79,805 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 7,106,955 | $139,652,000 | 2.69% |
| Malaga Cove Capital, LLC | 52,987 | $1,035,000 | 0.56% |
| PFM Health Sciences, LP | 1,699,100 | $33,387,000 | 0.49% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 75,000 | $1,474,000 | 0.43% |
| Spark Investment Management LLC | 320,400 | $6,295,000 | 0.36% |
| PFM Health Sciences, LP | 1,247,434 | $24,512,000 | 0.36% |
| Partner Investment Management, L.P. | 20,900 | $411,000 | 0.32% |
| Kazazian Asset Management, LLC | 14,454 | $284,000 | 0.27% |
| DLD Asset Management, LP | 271,500 | $5,327,000 | 0.26% |
| Partner Investment Management, L.P. | 15,516 | $305,000 | 0.23% |